Tissue Microarray (TMA) refers to the innovative practice of relocating multiple tissues sections from conventional histologic paraffin blocks so that the tissues from multiple samples can be observed on the same slide.It is a novel and useful tool to efficiently analyze gene expression in histological tissues.
Market Analysis and Insights: Global Tissue Microarray Market
The global Tissue Microarray market is projected to grow from US$ 7176.1 million in 2024 to US$ 10180 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Tissue Microarray market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Tissue Microarray, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Tissue Microarray, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tissue Microarray revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Tissue Microarray market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Tissue Microarray revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bio-Techne
Applied Microarrays
Z Biotech
OriGene
BioCat
Bio SB
Creative Bioarray
Abcam
BioIVT
Externautics
Protein Biotechnologies
US Biomax Inc.
Auria Biopankki
Segment by Type
Immunohistochemistry
Fluorescent In-Situ Hybridization
Frozen Tissue Array
Others
Segment by Application
Pharmaceutical and Biotechnological Companies
Research Organization
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Tissue Microarray in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tissue Microarray companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tissue Microarray revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tissue Microarray Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Immunohistochemistry
1.2.3 Fluorescent In-Situ Hybridization
1.2.4 Frozen Tissue Array
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tissue Microarray Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnological Companies
1.3.3 Research Organization
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tissue Microarray Market Perspective (2019-2030)
2.2 Global Tissue Microarray Growth Trends by Region
2.2.1 Tissue Microarray Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tissue Microarray Historic Market Size by Region (2019-2024)
2.2.3 Tissue Microarray Forecasted Market Size by Region (2025-2030)
2.3 Tissue Microarray Market Dynamics
2.3.1 Tissue Microarray Industry Trends
2.3.2 Tissue Microarray Market Drivers
2.3.3 Tissue Microarray Market Challenges
2.3.4 Tissue Microarray Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Tissue Microarray by Players
3.1.1 Global Tissue Microarray Revenue by Players (2019-2024)
3.1.2 Global Tissue Microarray Revenue Market Share by Players (2019-2024)
3.2 Global Tissue Microarray Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Tissue Microarray, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Tissue Microarray Market Concentration Ratio
3.4.1 Global Tissue Microarray Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tissue Microarray Revenue in 2023
3.5 Global Key Players of Tissue Microarray Head office and Area Served
3.6 Global Key Players of Tissue Microarray, Product and Application
3.7 Global Key Players of Tissue Microarray, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tissue Microarray Breakdown Data by Type
4.1 Global Tissue Microarray Historic Market Size by Type (2019-2024)
4.2 Global Tissue Microarray Forecasted Market Size by Type (2025-2030)
5 Tissue Microarray Breakdown Data by Application
5.1 Global Tissue Microarray Historic Market Size by Application (2019-2024)
5.2 Global Tissue Microarray Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tissue Microarray Market Size (2019-2030)
6.2 North America Tissue Microarray Market Size by Type
6.2.1 North America Tissue Microarray Market Size by Type (2019-2024)
6.2.2 North America Tissue Microarray Market Size by Type (2025-2030)
6.2.3 North America Tissue Microarray Market Share by Type (2019-2030)
6.3 North America Tissue Microarray Market Size by Application
6.3.1 North America Tissue Microarray Market Size by Application (2019-2024)
6.3.2 North America Tissue Microarray Market Size by Application (2025-2030)
6.3.3 North America Tissue Microarray Market Share by Application (2019-2030)
6.4 North America Tissue Microarray Market Size by Country
6.4.1 North America Tissue Microarray Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Tissue Microarray Market Size by Country (2019-2024)
6.4.3 North America Tissue Microarray Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Tissue Microarray Market Size (2019-2030)
7.2 Europe Tissue Microarray Market Size by Type
7.2.1 Europe Tissue Microarray Market Size by Type (2019-2024)
7.2.2 Europe Tissue Microarray Market Size by Type (2025-2030)
7.2.3 Europe Tissue Microarray Market Share by Type (2019-2030)
7.3 Europe Tissue Microarray Market Size by Application
7.3.1 Europe Tissue Microarray Market Size by Application (2019-2024)
7.3.2 Europe Tissue Microarray Market Size by Application (2025-2030)
7.3.3 Europe Tissue Microarray Market Share by Application (2019-2030)
7.4 Europe Tissue Microarray Market Size by Country
7.4.1 Europe Tissue Microarray Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Tissue Microarray Market Size by Country (2019-2024)
7.4.3 Europe Tissue Microarray Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Tissue Microarray Market Size (2019-2030)
8.2 China Tissue Microarray Market Size by Type
8.2.1 China Tissue Microarray Market Size by Type (2019-2024)
8.2.2 China Tissue Microarray Market Size by Type (2025-2030)
8.2.3 China Tissue Microarray Market Share by Type (2019-2030)
8.3 China Tissue Microarray Market Size by Application
8.3.1 China Tissue Microarray Market Size by Application (2019-2024)
8.3.2 China Tissue Microarray Market Size by Application (2025-2030)
8.3.3 China Tissue Microarray Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Tissue Microarray Market Size (2019-2030)
9.2 Asia Tissue Microarray Market Size by Type
9.2.1 Asia Tissue Microarray Market Size by Type (2019-2024)
9.2.2 Asia Tissue Microarray Market Size by Type (2025-2030)
9.2.3 Asia Tissue Microarray Market Share by Type (2019-2030)
9.3 Asia Tissue Microarray Market Size by Application
9.3.1 Asia Tissue Microarray Market Size by Application (2019-2024)
9.3.2 Asia Tissue Microarray Market Size by Application (2025-2030)
9.3.3 Asia Tissue Microarray Market Share by Application (2019-2030)
9.4 Asia Tissue Microarray Market Size by Region
9.4.1 Asia Tissue Microarray Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Tissue Microarray Market Size by Region (2019-2024)
9.4.3 Asia Tissue Microarray Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Tissue Microarray Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Tissue Microarray Market Size by Type
10.2.1 Middle East, Africa, and Latin America Tissue Microarray Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Tissue Microarray Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Tissue Microarray Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Tissue Microarray Market Size by Application
10.3.1 Middle East, Africa, and Latin America Tissue Microarray Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Tissue Microarray Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Tissue Microarray Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Tissue Microarray Market Size by Country
10.4.1 Middle East, Africa, and Latin America Tissue Microarray Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Tissue Microarray Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Tissue Microarray Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bio-Techne
11.1.1 Bio-Techne Company Details
11.1.2 Bio-Techne Business Overview
11.1.3 Bio-Techne Tissue Microarray Introduction
11.1.4 Bio-Techne Revenue in Tissue Microarray Business (2019-2024)
11.1.5 Bio-Techne Recent Developments
11.2 Applied Microarrays
11.2.1 Applied Microarrays Company Details
11.2.2 Applied Microarrays Business Overview
11.2.3 Applied Microarrays Tissue Microarray Introduction
11.2.4 Applied Microarrays Revenue in Tissue Microarray Business (2019-2024)
11.2.5 Applied Microarrays Recent Developments
11.3 Z Biotech
11.3.1 Z Biotech Company Details
11.3.2 Z Biotech Business Overview
11.3.3 Z Biotech Tissue Microarray Introduction
11.3.4 Z Biotech Revenue in Tissue Microarray Business (2019-2024)
11.3.5 Z Biotech Recent Developments
11.4 OriGene
11.4.1 OriGene Company Details
11.4.2 OriGene Business Overview
11.4.3 OriGene Tissue Microarray Introduction
11.4.4 OriGene Revenue in Tissue Microarray Business (2019-2024)
11.4.5 OriGene Recent Developments
11.5 BioCat
11.5.1 BioCat Company Details
11.5.2 BioCat Business Overview
11.5.3 BioCat Tissue Microarray Introduction
11.5.4 BioCat Revenue in Tissue Microarray Business (2019-2024)
11.5.5 BioCat Recent Developments
11.6 Bio SB
11.6.1 Bio SB Company Details
11.6.2 Bio SB Business Overview
11.6.3 Bio SB Tissue Microarray Introduction
11.6.4 Bio SB Revenue in Tissue Microarray Business (2019-2024)
11.6.5 Bio SB Recent Developments
11.7 Creative Bioarray
11.7.1 Creative Bioarray Company Details
11.7.2 Creative Bioarray Business Overview
11.7.3 Creative Bioarray Tissue Microarray Introduction
11.7.4 Creative Bioarray Revenue in Tissue Microarray Business (2019-2024)
11.7.5 Creative Bioarray Recent Developments
11.8 Abcam
11.8.1 Abcam Company Details
11.8.2 Abcam Business Overview
11.8.3 Abcam Tissue Microarray Introduction
11.8.4 Abcam Revenue in Tissue Microarray Business (2019-2024)
11.8.5 Abcam Recent Developments
11.9 BioIVT
11.9.1 BioIVT Company Details
11.9.2 BioIVT Business Overview
11.9.3 BioIVT Tissue Microarray Introduction
11.9.4 BioIVT Revenue in Tissue Microarray Business (2019-2024)
11.9.5 BioIVT Recent Developments
11.10 Externautics
11.10.1 Externautics Company Details
11.10.2 Externautics Business Overview
11.10.3 Externautics Tissue Microarray Introduction
11.10.4 Externautics Revenue in Tissue Microarray Business (2019-2024)
11.10.5 Externautics Recent Developments
11.11 Protein Biotechnologies
11.11.1 Protein Biotechnologies Company Details
11.11.2 Protein Biotechnologies Business Overview
11.11.3 Protein Biotechnologies Tissue Microarray Introduction
11.11.4 Protein Biotechnologies Revenue in Tissue Microarray Business (2019-2024)
11.11.5 Protein Biotechnologies Recent Developments
11.12 US Biomax Inc.
11.12.1 US Biomax Inc. Company Details
11.12.2 US Biomax Inc. Business Overview
11.12.3 US Biomax Inc. Tissue Microarray Introduction
11.12.4 US Biomax Inc. Revenue in Tissue Microarray Business (2019-2024)
11.12.5 US Biomax Inc. Recent Developments
11.13 Auria Biopankki
11.13.1 Auria Biopankki Company Details
11.13.2 Auria Biopankki Business Overview
11.13.3 Auria Biopankki Tissue Microarray Introduction
11.13.4 Auria Biopankki Revenue in Tissue Microarray Business (2019-2024)
11.13.5 Auria Biopankki Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bio-Techne
Applied Microarrays
Z Biotech
OriGene
BioCat
Bio SB
Creative Bioarray
Abcam
BioIVT
Externautics
Protein Biotechnologies
US Biomax Inc.
Auria Biopankki
听
听
*If Applicable.
